Should we expect neurological symptoms in the SARS-CoV-2 epidemic?
Identifieur interne : 000067 ( PubMed/Corpus ); précédent : 000066; suivant : 000068Should we expect neurological symptoms in the SARS-CoV-2 epidemic?
Auteurs : J. Matías-Guiu ; U. Gomez-Pinedo ; P. Montero-Escribano ; P. Gomez-Iglesias ; J. Porta-Etessam ; J A Matias-GuiuSource :
- Neurologia (Barcelona, Spain) [ 1578-1968 ] ; 2020.
Abstract
There is growing evidence that SARS-CoV-2 can gain access to the central nervous system (CNS). We revise the literature on coronavirus infection of the CNS associated with neurological diseases.
DOI: 10.1016/j.nrl.2020.03.001
PubMed: 32299636
Links to Exploration step
pubmed:32299636Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Should we expect neurological symptoms in the SARS-CoV-2 epidemic?</title>
<author><name sortKey="Matias Guiu, J" sort="Matias Guiu, J" uniqKey="Matias Guiu J" first="J" last="Matías-Guiu">J. Matías-Guiu</name>
<affiliation><nlm:affiliation>Servicio de Neurología, Instituto de Neurociencias, Hospital Clínico San Carlos, San Carlos, IdISSC, Madrid, España. Electronic address: neurol.hcsc@salud.madrid.org.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Gomez Pinedo, U" sort="Gomez Pinedo, U" uniqKey="Gomez Pinedo U" first="U" last="Gomez-Pinedo">U. Gomez-Pinedo</name>
<affiliation><nlm:affiliation>Servicio de Neurología, Instituto de Neurociencias, Hospital Clínico San Carlos, San Carlos, IdISSC, Madrid, España.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Montero Escribano, P" sort="Montero Escribano, P" uniqKey="Montero Escribano P" first="P" last="Montero-Escribano">P. Montero-Escribano</name>
<affiliation><nlm:affiliation>Servicio de Neurología, Instituto de Neurociencias, Hospital Clínico San Carlos, San Carlos, IdISSC, Madrid, España.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Gomez Iglesias, P" sort="Gomez Iglesias, P" uniqKey="Gomez Iglesias P" first="P" last="Gomez-Iglesias">P. Gomez-Iglesias</name>
<affiliation><nlm:affiliation>Servicio de Neurología, Instituto de Neurociencias, Hospital Clínico San Carlos, San Carlos, IdISSC, Madrid, España.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Porta Etessam, J" sort="Porta Etessam, J" uniqKey="Porta Etessam J" first="J" last="Porta-Etessam">J. Porta-Etessam</name>
<affiliation><nlm:affiliation>Servicio de Neurología, Instituto de Neurociencias, Hospital Clínico San Carlos, San Carlos, IdISSC, Madrid, España.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Matias Guiu, J A" sort="Matias Guiu, J A" uniqKey="Matias Guiu J" first="J A" last="Matias-Guiu">J A Matias-Guiu</name>
<affiliation><nlm:affiliation>Servicio de Neurología, Instituto de Neurociencias, Hospital Clínico San Carlos, San Carlos, IdISSC, Madrid, España.</nlm:affiliation>
</affiliation>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">PubMed</idno>
<date when="2020">2020</date>
<idno type="RBID">pubmed:32299636</idno>
<idno type="pmid">32299636</idno>
<idno type="doi">10.1016/j.nrl.2020.03.001</idno>
<idno type="wicri:Area/PubMed/Corpus">000067</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">000067</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en">Should we expect neurological symptoms in the SARS-CoV-2 epidemic?</title>
<author><name sortKey="Matias Guiu, J" sort="Matias Guiu, J" uniqKey="Matias Guiu J" first="J" last="Matías-Guiu">J. Matías-Guiu</name>
<affiliation><nlm:affiliation>Servicio de Neurología, Instituto de Neurociencias, Hospital Clínico San Carlos, San Carlos, IdISSC, Madrid, España. Electronic address: neurol.hcsc@salud.madrid.org.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Gomez Pinedo, U" sort="Gomez Pinedo, U" uniqKey="Gomez Pinedo U" first="U" last="Gomez-Pinedo">U. Gomez-Pinedo</name>
<affiliation><nlm:affiliation>Servicio de Neurología, Instituto de Neurociencias, Hospital Clínico San Carlos, San Carlos, IdISSC, Madrid, España.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Montero Escribano, P" sort="Montero Escribano, P" uniqKey="Montero Escribano P" first="P" last="Montero-Escribano">P. Montero-Escribano</name>
<affiliation><nlm:affiliation>Servicio de Neurología, Instituto de Neurociencias, Hospital Clínico San Carlos, San Carlos, IdISSC, Madrid, España.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Gomez Iglesias, P" sort="Gomez Iglesias, P" uniqKey="Gomez Iglesias P" first="P" last="Gomez-Iglesias">P. Gomez-Iglesias</name>
<affiliation><nlm:affiliation>Servicio de Neurología, Instituto de Neurociencias, Hospital Clínico San Carlos, San Carlos, IdISSC, Madrid, España.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Porta Etessam, J" sort="Porta Etessam, J" uniqKey="Porta Etessam J" first="J" last="Porta-Etessam">J. Porta-Etessam</name>
<affiliation><nlm:affiliation>Servicio de Neurología, Instituto de Neurociencias, Hospital Clínico San Carlos, San Carlos, IdISSC, Madrid, España.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Matias Guiu, J A" sort="Matias Guiu, J A" uniqKey="Matias Guiu J" first="J A" last="Matias-Guiu">J A Matias-Guiu</name>
<affiliation><nlm:affiliation>Servicio de Neurología, Instituto de Neurociencias, Hospital Clínico San Carlos, San Carlos, IdISSC, Madrid, España.</nlm:affiliation>
</affiliation>
</author>
</analytic>
<series><title level="j">Neurologia (Barcelona, Spain)</title>
<idno type="eISSN">1578-1968</idno>
<imprint><date when="2020" type="published">2020</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc><textClass></textClass>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en">There is growing evidence that SARS-CoV-2 can gain access to the central nervous system (CNS). We revise the literature on coronavirus infection of the CNS associated with neurological diseases.</div>
</front>
</TEI>
<pubmed><MedlineCitation Status="Publisher" Owner="NLM"><PMID Version="1">32299636</PMID>
<DateRevised><Year>2020</Year>
<Month>04</Month>
<Day>20</Day>
</DateRevised>
<Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1578-1968</ISSN>
<JournalIssue CitedMedium="Internet"><PubDate><Year>2020</Year>
<Month>Apr</Month>
<Day>06</Day>
</PubDate>
</JournalIssue>
<Title>Neurologia (Barcelona, Spain)</Title>
<ISOAbbreviation>Neurologia</ISOAbbreviation>
</Journal>
<ArticleTitle>Should we expect neurological symptoms in the SARS-CoV-2 epidemic?</ArticleTitle>
<ELocationID EIdType="pii" ValidYN="Y">S0213-4853(20)30065-7</ELocationID>
<ELocationID EIdType="doi" ValidYN="Y">10.1016/j.nrl.2020.03.001</ELocationID>
<Abstract><AbstractText Label="INTRODUCTION" NlmCategory="BACKGROUND">There is growing evidence that SARS-CoV-2 can gain access to the central nervous system (CNS). We revise the literature on coronavirus infection of the CNS associated with neurological diseases.</AbstractText>
<AbstractText Label="DEVELOPMENT" NlmCategory="METHODS">Neurological symptoms were rarely reported in the SARS-CoV and MERS-CoV epidemics, although isolated cases were described. There are also reports of cases of neurological symptoms associated with CoV-OC43 and CoV-229E infection. The presence of neurological lesions, especially demyelinating lesions in the mouse hepatitis virus model, may explain the mechanisms by which coronaviruses enter the CNS, particularly those related with the immune response. This may explain the presence of coronavirus in patients with multiple sclerosis. We review the specific characteristics of SARS-CoV-2 and address the question of whether the high number of cases may be associated with greater CNS involvement.</AbstractText>
<AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">Although neurological symptoms are not frequent in coronavirus epidemics, the high number of patients with SARS-CoV-2 infection may explain the presence of the virus in the CNS and increase the likelihood of early- or delayed-onset neurological symptoms. Follow-up of patients affected by the SARS-CoV-2 epidemic should include careful assessment of the CNS.</AbstractText>
<CopyrightInformation>Copyright © 2020. Publicado por Elsevier España, S.L.U.</CopyrightInformation>
</Abstract>
<AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Matías-Guiu</LastName>
<ForeName>J</ForeName>
<Initials>J</Initials>
<AffiliationInfo><Affiliation>Servicio de Neurología, Instituto de Neurociencias, Hospital Clínico San Carlos, San Carlos, IdISSC, Madrid, España. Electronic address: neurol.hcsc@salud.madrid.org.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Gomez-Pinedo</LastName>
<ForeName>U</ForeName>
<Initials>U</Initials>
<AffiliationInfo><Affiliation>Servicio de Neurología, Instituto de Neurociencias, Hospital Clínico San Carlos, San Carlos, IdISSC, Madrid, España.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Montero-Escribano</LastName>
<ForeName>P</ForeName>
<Initials>P</Initials>
<AffiliationInfo><Affiliation>Servicio de Neurología, Instituto de Neurociencias, Hospital Clínico San Carlos, San Carlos, IdISSC, Madrid, España.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Gomez-Iglesias</LastName>
<ForeName>P</ForeName>
<Initials>P</Initials>
<AffiliationInfo><Affiliation>Servicio de Neurología, Instituto de Neurociencias, Hospital Clínico San Carlos, San Carlos, IdISSC, Madrid, España.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Porta-Etessam</LastName>
<ForeName>J</ForeName>
<Initials>J</Initials>
<AffiliationInfo><Affiliation>Servicio de Neurología, Instituto de Neurociencias, Hospital Clínico San Carlos, San Carlos, IdISSC, Madrid, España.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Matias-Guiu</LastName>
<ForeName>J A</ForeName>
<Initials>JA</Initials>
<AffiliationInfo><Affiliation>Servicio de Neurología, Instituto de Neurociencias, Hospital Clínico San Carlos, San Carlos, IdISSC, Madrid, España.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<Language>spa</Language>
<PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType>
<PublicationType UI="D016454">Review</PublicationType>
</PublicationTypeList>
<VernacularTitle>¿Es esperable que haya cuadros neurológicos por la pandemia por SARS-CoV-2?</VernacularTitle>
<ArticleDate DateType="Electronic"><Year>2020</Year>
<Month>04</Month>
<Day>06</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo><Country>Spain</Country>
<MedlineTA>Neurologia</MedlineTA>
<NlmUniqueID>9005460</NlmUniqueID>
<ISSNLinking>0213-4853</ISSNLinking>
</MedlineJournalInfo>
<CitationSubset>IM</CitationSubset>
<KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Central nervous system</Keyword>
<Keyword MajorTopicYN="N">Coronavirus</Keyword>
<Keyword MajorTopicYN="N">Esclerosis múltiple</Keyword>
<Keyword MajorTopicYN="N">MERS-CoV</Keyword>
<Keyword MajorTopicYN="N">Mouse hepatitis virus</Keyword>
<Keyword MajorTopicYN="N">Multiple sclerosis</Keyword>
<Keyword MajorTopicYN="N">Neurological symptoms</Keyword>
<Keyword MajorTopicYN="N">SARS-CoV</Keyword>
<Keyword MajorTopicYN="N">SARS-CoV-2</Keyword>
<Keyword MajorTopicYN="N">Sistema nervioso central</Keyword>
<Keyword MajorTopicYN="N">Síntomas neurológicos</Keyword>
<Keyword MajorTopicYN="N">Virus murino de la hepatitis</Keyword>
</KeywordList>
</MedlineCitation>
<PubmedData><History><PubMedPubDate PubStatus="received"><Year>2020</Year>
<Month>03</Month>
<Day>27</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="accepted"><Year>2020</Year>
<Month>03</Month>
<Day>31</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="entrez"><Year>2020</Year>
<Month>4</Month>
<Day>18</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="pubmed"><Year>2020</Year>
<Month>4</Month>
<Day>18</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="medline"><Year>2020</Year>
<Month>4</Month>
<Day>18</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
</History>
<PublicationStatus>aheadofprint</PublicationStatus>
<ArticleIdList><ArticleId IdType="pubmed">32299636</ArticleId>
<ArticleId IdType="pii">S0213-4853(20)30065-7</ArticleId>
<ArticleId IdType="doi">10.1016/j.nrl.2020.03.001</ArticleId>
<ArticleId IdType="pmc">PMC7136883</ArticleId>
</ArticleIdList>
<ReferenceList><Reference><Citation>Emerg Infect Dis. 2004 Feb;10(2):342-4</Citation>
<ArticleIdList><ArticleId IdType="pubmed">15030709</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>Front Cell Neurosci. 2018 Oct 26;12:386</Citation>
<ArticleIdList><ArticleId IdType="pubmed">30416428</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>Adv Exp Med Biol. 2014;807:75-96</Citation>
<ArticleIdList><ArticleId IdType="pubmed">24619619</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>Arch Neurol. 2004 Nov;61(11):1669-73</Citation>
<ArticleIdList><ArticleId IdType="pubmed">15534177</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>Arch Neurol. 2005 Jul;62(7):1113-7</Citation>
<ArticleIdList><ArticleId IdType="pubmed">16009768</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>J Virol. 2012 Jan;86(1):81-93</Citation>
<ArticleIdList><ArticleId IdType="pubmed">22013052</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>Eur Rev Med Pharmacol Sci. 2020 Mar;24(5):2781-2783</Citation>
<ArticleIdList><ArticleId IdType="pubmed">32196628</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>J Virol. 1997 Jan;71(1):800-6</Citation>
<ArticleIdList><ArticleId IdType="pubmed">8985420</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>Hum Vaccin Immunother. 2019;15(2):496-502</Citation>
<ArticleIdList><ArticleId IdType="pubmed">30235060</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>J Infect Dis. 2013 Jun 1;207(11):1743-52</Citation>
<ArticleIdList><ArticleId IdType="pubmed">23532101</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>Acta Neuropathol. 2001 Jun;101(6):601-4</Citation>
<ArticleIdList><ArticleId IdType="pubmed">11515789</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>J Virol. 1999 Apr;73(4):3326-37</Citation>
<ArticleIdList><ArticleId IdType="pubmed">10074187</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>J Virol. 1999 Apr;73(4):3338-50</Citation>
<ArticleIdList><ArticleId IdType="pubmed">10074188</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>Adv Exp Med Biol. 1998;440:635-9</Citation>
<ArticleIdList><ArticleId IdType="pubmed">9782339</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>Virology. 2009 Dec 20;395(2):255-67</Citation>
<ArticleIdList><ArticleId IdType="pubmed">19846189</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>Virology. 1992 Nov;191(1):502-5</Citation>
<ArticleIdList><ArticleId IdType="pubmed">1413524</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>Emerg Microbes Infect. 2020 Dec;9(1):221-236</Citation>
<ArticleIdList><ArticleId IdType="pubmed">31987001</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>Neurology. 2003 Dec 23;61(12):1820-1</Citation>
<ArticleIdList><ArticleId IdType="pubmed">14694063</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>J Neurol. 2004 Oct;251(10):1227-31</Citation>
<ArticleIdList><ArticleId IdType="pubmed">15503102</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>Mov Disord. 1992;7(2):153-8</Citation>
<ArticleIdList><ArticleId IdType="pubmed">1316552</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>J Neuroimmune Pharmacol. 2009 Jun;4(2):200-12</Citation>
<ArticleIdList><ArticleId IdType="pubmed">19016329</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>J Virol. 2000 Oct;74(19):8913-21</Citation>
<ArticleIdList><ArticleId IdType="pubmed">10982334</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>J Virol. 2015 Oct;89(19):9896-908</Citation>
<ArticleIdList><ArticleId IdType="pubmed">26202229</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>Crit Rev Immunol. 2010;30(2):119-30</Citation>
<ArticleIdList><ArticleId IdType="pubmed">20370625</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>Int J Antimicrob Agents. 2020 Mar;55(3):105924</Citation>
<ArticleIdList><ArticleId IdType="pubmed">32081636</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>Virus Res. 2014 Dec 19;194:145-58</Citation>
<ArticleIdList><ArticleId IdType="pubmed">25281913</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>Adv Virus Res. 2018;100:163-188</Citation>
<ArticleIdList><ArticleId IdType="pubmed">29551135</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>Saudi Med J. 2017 Feb;38(2):196-200</Citation>
<ArticleIdList><ArticleId IdType="pubmed">28133694</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>Virus Res. 2015 Apr 16;202:89-100</Citation>
<ArticleIdList><ArticleId IdType="pubmed">25432065</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>Front Immunol. 2018 Dec 20;9:3022</Citation>
<ArticleIdList><ArticleId IdType="pubmed">30619363</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>Pediatrics. 2004 Jan;113(1 Pt 1):e73-6</Citation>
<ArticleIdList><ArticleId IdType="pubmed">14702500</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>J Gen Virol. 1995 Dec;76 ( Pt 12):3201-4</Citation>
<ArticleIdList><ArticleId IdType="pubmed">8847530</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>J Pediatr Neurosci. 2015 Jul-Sep;10(3):280-1</Citation>
<ArticleIdList><ArticleId IdType="pubmed">26557177</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>Ann Neurol. 1992 May;31(5):525-33</Citation>
<ArticleIdList><ArticleId IdType="pubmed">1596089</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>PLoS One. 2014 Oct 31;9(10):e111351</Citation>
<ArticleIdList><ArticleId IdType="pubmed">25360880</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>J Gen Virol. 1982 Jun;60(Pt 2):307-14</Citation>
<ArticleIdList><ArticleId IdType="pubmed">7108490</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>Arch Virol. 1992;122(1-2):35-44</Citation>
<ArticleIdList><ArticleId IdType="pubmed">1309644</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>Neurology. 1982 Mar;32(3):292-5</Citation>
<ArticleIdList><ArticleId IdType="pubmed">6278362</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>Microb Pathog. 1994 May;16(5):349-57</Citation>
<ArticleIdList><ArticleId IdType="pubmed">7815918</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>J Virol. 2018 Aug 16;92(17):</Citation>
<ArticleIdList><ArticleId IdType="pubmed">29925652</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>J Can Chiropr Assoc. 2011 Mar;55(1):32-9</Citation>
<ArticleIdList><ArticleId IdType="pubmed">21403780</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>Science. 1980 Aug 22;209(4459):933-4</Citation>
<ArticleIdList><ArticleId IdType="pubmed">7403860</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>Eur J Clin Microbiol Infect Dis. 2007 Feb;26(2):121-9</Citation>
<ArticleIdList><ArticleId IdType="pubmed">17219094</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>Curr Top Microbiol Immunol. 2001;253:247-71</Citation>
<ArticleIdList><ArticleId IdType="pubmed">11417138</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>Lab Invest. 1988 Jan;58(1):31-6</Citation>
<ArticleIdList><ArticleId IdType="pubmed">2826881</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>J Neurol Sci. 1976 May;28(1):121-6</Citation>
<ArticleIdList><ArticleId IdType="pubmed">932771</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>Int J Infect Dis. 2014 Dec;29:301-6</Citation>
<ArticleIdList><ArticleId IdType="pubmed">25303830</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>N Engl J Med. 2016 Aug 4;375(5):497-8</Citation>
<ArticleIdList><ArticleId IdType="pubmed">27518687</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>Infection. 2015 Aug;43(4):495-501</Citation>
<ArticleIdList><ArticleId IdType="pubmed">25600929</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>J Clin Neurol. 2017 Jul;13(3):227-233</Citation>
<ArticleIdList><ArticleId IdType="pubmed">28748673</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>Biochem Biophys Res Commun. 2004 Jul 9;319(4):1216-21</Citation>
<ArticleIdList><ArticleId IdType="pubmed">15194496</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>Lancet. 1985 Jun 8;1(8441):1313-5</Citation>
<ArticleIdList><ArticleId IdType="pubmed">2860501</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>Eur Rev Med Pharmacol Sci. 2020 Feb;24(4):2162-2164</Citation>
<ArticleIdList><ArticleId IdType="pubmed">32141586</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>Lancet. 2020 Feb 15;395(10223):507-513</Citation>
<ArticleIdList><ArticleId IdType="pubmed">32007143</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>Virology. 1984 Sep;137(2):347-57</Citation>
<ArticleIdList><ArticleId IdType="pubmed">6091333</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>Adv Exp Med Biol. 1987;218:287-95</Citation>
<ArticleIdList><ArticleId IdType="pubmed">2829542</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>Virology. 2003 Oct 10;315(1):20-33</Citation>
<ArticleIdList><ArticleId IdType="pubmed">14592756</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>Nat Rev Immunol. 2011 May;11(5):318-29</Citation>
<ArticleIdList><ArticleId IdType="pubmed">21508982</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>Emerg Microbes Infect. 2020 Dec;9(1):386-389</Citation>
<ArticleIdList><ArticleId IdType="pubmed">32065057</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>J Neurol. 1993 Jul;240(7):417-22</Citation>
<ArticleIdList><ArticleId IdType="pubmed">8410082</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>Virology. 2006 Jun 5;349(2):335-46</Citation>
<ArticleIdList><ArticleId IdType="pubmed">16527322</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>J Neurovirol. 2005 Aug;11(4):395-402</Citation>
<ArticleIdList><ArticleId IdType="pubmed">16162482</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>Methods Mol Biol. 2015;1282:1-23</Citation>
<ArticleIdList><ArticleId IdType="pubmed">25720466</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>Acta Neurol Taiwan. 2005 Sep;14(3):113-9</Citation>
<ArticleIdList><ArticleId IdType="pubmed">16252612</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>Virology. 2007 Oct 25;367(2):367-74</Citation>
<ArticleIdList><ArticleId IdType="pubmed">17631932</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>Clin Microbiol Rev. 2007 Jan;20(1):49-78</Citation>
<ArticleIdList><ArticleId IdType="pubmed">17223623</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>Intervirology. 2016;59(3):163-169</Citation>
<ArticleIdList><ArticleId IdType="pubmed">28103598</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
</PubmedData>
</pubmed>
</record>
Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Sante/explor/SrasV1/Data/PubMed/Corpus
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000067 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/PubMed/Corpus/biblio.hfd -nk 000067 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien |wiki= Sante |area= SrasV1 |flux= PubMed |étape= Corpus |type= RBID |clé= pubmed:32299636 |texte= Should we expect neurological symptoms in the SARS-CoV-2 epidemic? }}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Corpus/RBID.i -Sk "pubmed:32299636" \ | HfdSelect -Kh $EXPLOR_AREA/Data/PubMed/Corpus/biblio.hfd \ | NlmPubMed2Wicri -a SrasV1
![]() | This area was generated with Dilib version V0.6.33. | ![]() |